Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Pharmaceuticals Secures USD $1.9 Million Sales Contract for SmoothX 2% (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News BioNTech SE BNTX

Healthcare Biotechnology
BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. The Company is providing technologies including mRNA-based therapies, cell therapies, small molecules and antibodies, which can be utilized for specific purposes or can be even combined with each other in a... see more

Recent & Breaking News (NDAQ:BNTX)

Class Action Filed Against BioNTech SE (BNTX) - March 12, 2024 Deadline to Join - Contact Levi & Korsinsky

Accesswire February 22, 2024

UPCOMING BNTX DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds BioNTech SE Investors to Join the Class Action Lawsuit!

Accesswire February 22, 2024

Investors who lost money on BioNTech SE (BNTX) should contact Levi & Korsinsky about pending Class Action - BNTX

Accesswire February 21, 2024

BIONTECH SHAREHOLDER ACTION REMINDER: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In BioNTech To Contact Him Directly To Discuss Their Options

PR Newswire February 21, 2024

INVESTOR ACTION ALERT: The Schall Law Firm Encourages Investors in BioNTech SE with Losses of $100,000 to Contact the Firm

Newsfile February 21, 2024

BioNTech SE Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before March 12, 2024 to Discuss Your Rights - BNTX

Accesswire February 21, 2024

BNTX SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman LLC Reminds BioNTech SE Investors to Join the Class Action Lawsuit!

Accesswire February 21, 2024

BioNTech Ongoing Deadline Alert

Newsfile February 20, 2024

BioNTech Notice: Kessler Topaz Meltzer & Check, LLP Notifies Investors of Securities Fraud Class Action Lawsuit Filed against BioNTech SE (BNTX)

Newsfile February 20, 2024

BioNTech SE Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - BNTX

Accesswire February 20, 2024

Shareholders That Lost Money on BioNTech SE(BNTX) Should Contact Levi & Korsinsky About Pending Class Action - BNTX

Accesswire February 20, 2024

SHAREHOLDER ACTION NOTICE: The Schall Law Firm Encourages Investors in BioNTech SE with Losses of $100,000 to Contact the Firm

Newsfile February 20, 2024

BNTX Investors Have Opportunity to Lead BioNTech SE Securities Fraud Lawsuit

PR Newswire February 20, 2024

Investors who lost money on BioNTech SE(BNTX) should contact Levi & Korsinsky about pending Class Action - BNTX

Accesswire February 20, 2024

Lost Money on BioNTech SE(BNTX)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky

PR Newswire February 20, 2024

BioNTech SE Sued for Securities Law Violations - Contact Levi & Korsinsky Before March 12, 2024 to Discuss Your Rights - BNTX

Accesswire February 20, 2024

Class Action Filed Against BioNTech SE (BNTX) Seeking Recovery for Investors - Contact Levi & Korsinsky

Accesswire February 20, 2024

BNTX SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman LLC Reminds BioNTech SE Investors to Join the Class Action Lawsuit!

Accesswire February 20, 2024

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages BioNTech SE Investors to Secure Counsel Before Important Deadline in Securities Class Action - BNTX

Newsfile February 19, 2024

Levi & Korsinsky Notifies Shareholders of BioNTech SE(BNTX) of a Class Action Lawsuit and an Upcoming Deadline

Accesswire February 19, 2024